Our results suggested that shikonin may possess anticancer effects on EEC via mediating miR-106b/phosphatase and tensin homolog (PTEN)/AKT/mTOR signaling pathway and act as a potential therapeutic agent for the treatment of EEC. Here, AKT1 is linked to exstrophy-epispadias complex.